Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sounds exciting but maybe try some AI to help with these posts to fix the grammar mistakes !
Holy Cow who said sugar molecules were baaaahhhdASS LOL
$BIXT Galectin Antagonists (antiviral molecules) Designed by AI, and could IMO end the need for many vaccines... Already has 2 Phase III trials in two countries ready
https://cdn.discordapp.com/attachments/1151863925730709614/1189297970638770196/image.png?ex=659da70c&is=658b320c&hm=0d052d304423243a4482892e73081064016c79262a923a20137193cc387dbf3e&
Merry Christmas to all!
Note: many none performing stocks can many times fall victim to tax loss selling at the end of the year. Take advantage of this !
I’m adding all I can today, it’s like stealing candy from a baby!
Please read and share this with everyone, everyone you know!
https://www.zerohedge.com/news/2023-12-12/disease-x-resistance-futile
https://www.msn.com/en-us/health/medical/never-before-seen-virus-that-causes-malaria-like-illness-already-circulating/ar-AA1kYq4O?ocid=winp1taskbar&cvid=dc54595b97124bf69530bcf6fe4476f1&ei=46
Never-before-seen virus that causes malaria-like illness 'already circulating'
Story by Katherine Fidler •
14h
Need BIXT bad should be the main source of survival of this crap
Yes. The hardest thing in trading is to reenter a market at a higher price than where you exited it previously!
Ditto...All of my other stock choices have been egregious flops thus far and I'm hoping those two will redeem my portfolio some day...We'll see...
I'm certainly banking on it...And following the inevitable sell-off by profit-taking shareholders I'm keeping fingers and toes crossed that Bioxytran will turn into an industry Goliath like Nividia and Broadcom Semiconductors did after I bought and foolishly sold back when each stock was trading at $25... (Tickers NVDA & AVGO) Needless to say I get seriously ill when I take a look at where those two stocks are trading now versus where it was when I took my meager 20% profit on both years ago...Sigh...
When I click on that link I get an error message stating "PAGE NOT FOUND"...
Not everyone that owns a few shares posts daily..This is my first post..have owned Bixt shares for awhile and believe I am in the right place at the right time.$IFUS and $BIXT top two holdings
So true
Something is close to happening. I think in 60 days or less
.50 minimum coming soon for starters
BIG RIG
Or a JV or Multiple JV deals will send it flying. Once they get several versions to Market that patent could be worth 50 Billion dollars. They just need the non dilutive JV funding deal(s) to close and trials completed, and Boom, this turns into next Moderna stock rally like no one had seen before 2020..
Glad to see you here!
Enjoy thanksgiving!
I added $BIXT.
Interesting very recent article:
https://www.linkedin.com/pulse/galectin-antagonists-send-cancer-its-knees-who-strike-michael-sheikh-ykzmc%3FtrackingId=QJP3RG9YRNaoKUCfc6S8yA%253D%253D/?trackingId=QJP3RG9YRNaoKUCfc6S8yA%3D%3D
** ….. All of the article is very good… the last 2 paragraphs talk about Bixt…
This is extremely undervalued
Added here, another one of a kind otc, do your DD here, https://www.otcmarkets.com/stock/BIXT/news/Bioxytran-Gets-Broad-Patent-Coverage-on-60-Viruses?id=418645
Most current antivirals disturb the replication of a virus once it's already in the cell. BioxyTran CCO Mike Sheikh details how #Bioxytran's Galectin Inhibitor kills the virus BEFORE IT EVEN ENTERS the cell. $BIXT Learn more here: https://t.co/WfOuNTvPHm pic.twitter.com/r0bPYa9sgp
— Bioxytran Inc. (@BioxytranInc) October 27, 2023
$BIXT Twitter/X page...Give them a follow
https://twitter.com/BioxytranInc
If true this is going to absolutely explode. This could POSSIBLY be revolutionary. Worth a shot
BIG RIG
Trading upwards in its recent trading range now... Bet we see .20+ this week
Wow looking good here
As far as I'm concerned it can't happen quickly enough
This has the potential for a buyout or merger with a major. This is unbelievable and under the radar. Huge upside from here
BIG RIG
What is a global patent for a non toxic to humans, A-Z viral cure worth? One hell of lot more that the 20 Million dollar market it closed at a day ago that is for sure. $BIXT
BIXT news just came out on the global patent for the non toxic to human antiviral that had a perfect drug trial and cured Covid19 in days, putting Paxlovid to shame and the BIXT carbohydrate based drug only took 2 days not 7-10 days and the BIXT had no bounce back of the covid ( so it was1 of only 2 perfect drug trials in decade, the other was the Hep C antiviral cure that is worth billions of dollars)
https://www.otcmarkets.com/stock/BIXT/news/Bioxytran-Gets-Broad-Patent-Coverage-on-60-Viruses?id=418645
Bioxytran Gets Broad Patent Coverage on 60+ Viruses
Press Release | 10/24/2023
Claims cover method of treating a viral infection with a lectin-binding carbohydrate
BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical-stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral diseases, announced that the U.S Patent and Trademark Office (USPTO) has published the Company’s patent application WO2023178228A1 Lectin-binding carbohydrates for treating viral infections. The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.
This is world wide patent people, not just the USA!!!
This could soon be the biggest thing since the invention of Penicillin, the first Antibiotic for pathogenic bacteria
This is the most undervalued Bio-Tech stock there is now!!!
That's a really good point. With that in mind, I don't understand why this board has such low attendance. Bioxytran would appear to be one pink sheet stock that merits a little more excitement--unless I'm missing something about the company's true potential...
It just dawned on me what the huge potential revenue/applications for the
BIXT antiviral drugs would be for use to protect against terrorist Bio-warfare risks.
DOD should be funding this company.
https://medium.com/[@ userid=1]-68-million-commitment-c6c9c3d2d859
At a trading price of $0.173, Bioxytran, Inc. ($BIXT) is a company to watch. With a 30-day average volume of over 208K, investor interest is growing as they pioneer solutions for hypoxia.
Let's hope that even one of the fifty or so possible dance partners in the pharmaceutical sector decides to throw in with Bioxytran and make a lot of shareholders solvent and happy far into the future...We'll see...Hopefully soon...
$BIXT NEWS VIDEO
@BioxytranInc
(OTCQB: BIXT)
Excellent talk today. Stock responses to the mentioning of a list of small cash rich companies that are perfect candidates to partner with BIXT!
$BIXT CEO Update @BioxytranInc (OTCQB: BIXT) Bioxytran, Inc. is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia.
$BIXT Emerging Growth Conference
October 05, 2023
Followers
|
45
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1219
|
Created
|
03/23/10
|
Type
|
Free
|
Moderators i_like_bb_stock |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |